Standout Papers

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Hea... 2000 2026 2008 2017 6.0k
  1. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease (2006)
    Robert O. Bonow, Blasé A. Carabello et al. Circulation
  2. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease (2014)
    Rick A. Nishimura, Catherine M Otto et al. Journal of the American College of Cardiology
  3. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease (2017)
    Rick A. Nishimura, Catherine M Otto et al. Journal of the American College of Cardiology
  4. The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction (2000)
    Raymond J. Kim, Edwin Wu et al. New England Journal of Medicine
  5. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease (2014)
    Rick A. Nishimura, Catherine M Otto et al. Circulation
  6. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation (2017)
    William A. Zoghbi, David Adams et al. Journal of the American Society of Echocardiography
  7. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines (2020)
    Catherine M Otto, Rick A. Nishimura et al. Circulation
  8. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary (2014)
    Rick A. Nishimura, Catherine M Otto et al. Circulation
  9. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine (2011)
    Douglas L. Mann, Douglas P. Zipes et al. Medical Entomology and Zoology
  10. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease (2008)
    Robert O. Bonow, Blasé A. Carabello et al. Journal of the American College of Cardiology
  11. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy (2011)
    Bernard J. Gersh, Barry J. Maron et al. Circulation
  12. AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update (2006)
    Sidney C. Smith, Jerilyn K. Allen et al. Circulation
  13. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (2017)
    Rick A. Nishimura, Catherine M Otto et al. Circulation
  14. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines (2020)
    Catherine M Otto, Rick A. Nishimura et al. Circulation
  15. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update (2011)
    Sidney C. Smith, Emelia J. Benjamin et al. Circulation
  16. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary (2014)
    Rick A. Nishimura, Catherine M Otto et al. Journal of the American College of Cardiology
  17. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study (2003)
    Anja Wagner, Heiko Mahrholdt et al. The Lancet
  18. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy (2011)
    Bernard J. Gersh, Barry J. Maron et al. Journal of the American College of Cardiology
  19. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease (2008)
    Robert O. Bonow, Blasé A. Carabello et al. Circulation
  20. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease (2020)
    Catherine M Otto, Rick A. Nishimura et al. Journal of the American College of Cardiology
  21. Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery Stents (2007)
    Cindy L. Grines, Robert O. Bonow et al. Circulation
  22. Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction (2014)
    Sanjiv J. Shah, Daniel H. Katz et al. Circulation
  23. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update (2011)
    Sidney C. Smith, Emelia J. Benjamin et al. Journal of the American College of Cardiology
  24. Hypertrophic Cardiomyopathy (1987)
    Barry J. Maron, Robert O. Bonow et al. New England Journal of Medicine
  25. Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure (2003)
    Richard W. Nesto, David S.H. Bell et al. Circulation
  26. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials (2008)
    Jay S. Skyler, Richard M. Bergenstal et al. Diabetes Care
  27. Chronic Heart Failure in the United States (1998)
    Mihai Gheorghiade, Robert O. Bonow Circulation
  28. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary (2011)
    Bernard J. Gersh, Barry J. Maron et al. Circulation
  29. Enhanced Detection of Ischemic but Viable Myocardium by the Reinjection of Thallium after Stress-Redistribution Imaging (1990)
    Vasken Dilsizian, Thomas P. Rocco et al. New England Journal of Medicine
  30. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy (2016)
    Eric J. Velazquez, Kerry L. Lee et al. New England Journal of Medicine
  31. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction (2001)
    Edwin Wu, Robert M. Judd et al. The Lancet
  32. Rehospitalization for Heart Failure (2012)
    Mihai Gheorghiade, Muthiah Vaduganathan et al. Journal of the American College of Cardiology
  33. Human Aortic Valve Calcification Is Associated With an Osteoblast Phenotype (2003)
    Nalini M. Rajamannan, Malayannan Subramaniam et al. Circulation
  34. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update (2001)
    Sidney C. Smith, Steven N. Blair et al. Journal of the American College of Cardiology
  35. AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update (2006)
    Sidney C. Smith, Jerilyn K. Allen et al. Journal of the American College of Cardiology
  36. Impaired left ventricular diastolic filling in patients with coronary artery disease: assessment with radionuclide angiography. (1981)
    Robert O. Bonow, Stephen L. Bacharach et al. Circulation
  37. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary (2020)
    Catherine M Otto, Rick A. Nishimura et al. Journal of the American College of Cardiology
  38. Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction (2016)
    Peter C. Westman, Michael J. Lipinski et al. Journal of the American College of Cardiology
  39. Valve-Related Hemodynamics Mediate Human Bicuspid Aortopathy (2015)
    David G. Guzzardi, Alex J. Barker et al. Journal of the American College of Cardiology
  40. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis (2015)
    Barry J. Maron, James E. Udelson et al. Circulation
  41. PCI and CABG for Treating Stable Coronary Artery Disease (2019)
    Torsten Doenst, Axel Haverich et al. Journal of the American College of Cardiology
  42. Targeting cardiovascular inflammation: next steps in clinical translation (2020)
    Patrick R. Lawler, Deepak L. Bhatt et al. European Heart Journal

Immediate Impact

5 from Science/Nature 88 standout
Sub-graph 1 of 17

Citing Papers

Blinded, randomized trial of sonographer versus AI cardiac function assessment
2023 StandoutNature
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
2018 Standout
23 intermediate papers

Works of Robert O. Bonow being referenced

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation
2017 Standout
and 28 more

Author Peers

Author Last Decade Papers Cites
Robert O. Bonow 62840 19835 20772 20043 561 77.8k
Eric D. Peterson 45772 7784 20943 16839 1.2k 77.4k
Patrizio Lancellotti 45290 13837 11988 12289 465 54.2k
Bernard J. Gersh 60179 13371 18709 7016 1.1k 74.3k
Valentı́n Fuster 52301 22414 33107 10702 1.3k 98.0k
David R. Holmes 62505 24862 41217 8390 1.4k 87.2k
Jeroen J. Bax 58530 26184 21074 8517 1.6k 73.0k
Christopher B. Granger 48225 9696 13453 5452 833 62.0k
Philippe Gabríel Steg 54884 9926 29325 5494 1.1k 74.8k
Marc A. Pfeffer 62884 9146 25888 7323 593 94.5k
Emelia J. Benjamin 68687 9327 11568 11958 766 98.8k

All Works

Loading papers...

Rankless by CCL
2026